81 results in Exploration of Digestive Diseases
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Case Report
Remarkable alpha-fetoprotein elevation and pseudo-infarction of cirrhotic liver: case report
Maged Tharwat Elghannam ... Mohammed Darwish ELTalkawy
Published: March 29, 2024 Explor Dig Dis. 2024;3:86–91
Open Access
Review
Liver metastatic colonization by invasive cancer cells: a review of potential biomarkers with mitochondrial involvement
Daniel L. Pouliquen
Published: March 22, 2024 Explor Dig Dis. 2024;3:69–85
This article belongs to the special issue Mitochondria and Lipid Signalling in Liver Diseases
Open Access
Review
The central role of mitochondrial metabolism in hepatic steatosis
Sanda Win ... Filbert Win Min Aung
Published: February 29, 2024 Explor Dig Dis. 2024;3:42–68
This article belongs to the special issue Mitochondria and Lipid Signalling in Liver Diseases
Open Access
Review
SERPINB3 in fibrogenic chronic liver diseases and primary liver cancers
Patrizia Pontisso, Maurizio Parola
Published: February 28, 2024 Explor Dig Dis. 2024;3:22–41
This article belongs to the special issue Fibrosis and Hepatobiliary Cancer
Open Access
Review
Bile as a liquid biopsy matrix: potential applications and limitations
Maria Arechederra ... Carmen Berasain
Published: February 04, 2024 Explor Dig Dis. 2024;3:5–21
Open Access
Editorial
Precision medicine in chemotherapy: Is there room for advancement in colorectal cancer?
Michele Ghidini
Published: January 18, 2024 Explor Dig Dis. 2024;3:2–4
This article belongs to the special issue Latest Updates in the Endoscopic, Surgical and Medical Treatment of Resectable and Advanced Gastrointestinal Cancers
Open Access
Correction
Correction: Familial achalasia isolated or syndromic: about 18 families
Editorial Office
Published: January 11, 2024 Explor Dig Dis 2024;3:1
Open Access
Review
Deciphering the liver enigma: distinguishing drug-induced liver injury and metabolic dysfunction-associated steatotic liver disease—a comprehensive narrative review
Miren García-Cortés ... Alberto García-García
Published: December 27, 2023 Explor Dig Dis 2023;2:318–336
This article belongs to the special issue Drug-induced Liver Injury: From Bench to Clinical Application
Open Access
Original Article
The significance of chronic hyperglycemia for the reduced efficacy of eradication therapy in patients with type 2 diabetes mellitus and for Helicobacter pylori survival
Luiza Gilmanovna Bektemirova ... Vasiliy Ivanovich Reshetnyak
Published: December 27, 2023 Explor Dig Dis. 2023;2:305–317
This article belongs to the special issue Helicobacter Pylori and Infection: Genomics, Diagnosis, Pathogenesis, Antibiotic Resistance, Microbiota, Cancer, Prevention and Therapeutics
Open Access
Original Article
Impact of the direct acting antivirals on chronic hepatitis C prevalence on the Swiss organ transplantation list: a retrospective analysis
Luis Falcato ... Franz Immer
Published: December 25, 2023 Explor Dig Dis. 2023;2:297–304
This article belongs to the special issue Chronic Hepatitis B and C
Open Access
Review
Therapeutic targets for metabolic dysfunction-associated steatotic liver disease and their roles in hepatocellular carcinoma
Chenyu Wei ... Xianguang Yang
Published: December 13, 2023 Explor Dig Dis. 2023;2:282–296
This article belongs to the special issue Cellular and Molecular Targets for NAFLD or MAFLD Treatments and Their Functions in Liver Fibrosis, Cirrhosis, and Cancer
Open Access
Original Article
Familial achalasia isolated or syndromic: about 18 families
Amar Tebaibia ... Nadia Oumnia
Published: October 26, 2023 Explor Dig Dis. 2023;2:276–281
This article belongs to the special issue Advances in Hepato-gastroenterology: Diagnosis, Prognostication, and Disease Stratification
Open Access
Review
Molecular mechanisms of metabolic disease-associated hepatic inflammation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Chunye Zhang ... Ming Yang
Published: October 25, 2023 Explor Dig Dis. 2023;2:246–275
This article belongs to the special issue Cellular and Molecular Targets for NAFLD or MAFLD Treatments and Their Functions in Liver Fibrosis, Cirrhosis, and Cancer
Open Access
Review
Interplay of autophagy, apoptosis, and senescence in primary biliary cholangitis
Elias Kouroumalis ... Argyro Voumvouraki
Published: October 16, 2023 Explor Dig Dis. 2023;2:223–245
This article belongs to the special issue CHOLESTASIS
Open Access
Review
Drug-induced cholestasis: causative agents and challenges in diagnosis and management
Jose M. Pinazo-Bandera ... Miren García-Cortés
Published: September 18, 2023 Explor Dig Dis. 2023;2:202–222
This article belongs to the special issue CHOLESTASIS
Open Access
Review
Principles of risk stratification in nonalcoholic fatty liver disease. A narrative review emphasizing non-invasive strategies
Amedeo Lonardo
Published: August 30, 2023 Explor Dig Dis. 2023;2:188–201
This article belongs to the special issue Advances in Hepato-gastroenterology: Diagnosis, Prognostication, and Disease Stratification
Open Access
Original Article
Human liver stem cell-derived extracellular vesicles modulate long non-coding RNA expression profile in an in vivo model of non-alcoholic steatohepatitis
Giulia Chiabotto ... Stefania Bruno
Published: August 30, 2023 Explor Dig Dis. 2023;2:172–187
Open Access
Review
Pathophysiology of biochemical signs of primary biliary cholangitis
Vasiliy Ivanovich Reshetnyak, Igor Veniaminovich Maev
Published: August 27, 2023 Explor Dig Dis. 2023;2:149–171
This article belongs to the special issue CHOLESTASIS
Open Access
Review
Ultra-processed food consumption and the risk of non-alcoholic fatty liver disease—What are the proposed mechanisms?
Franziska A. Hägele ... Anja Bosy-Westphal
Published: August 24, 2023 Explor Dig Dis. 2023;2:133–148
Open Access
Review
Alcohol-related liver disease: also a question of what you drink?
Finn Jung ... Ina Bergheim
Published: June 30, 2023 Explor Dig Dis. 2023;2:118–132
Journal Information